Overview
Jefferies analysts state that the Federal Reserve’s policy emphasis in 2027 will be the primary driver of performance across the chemical sector, with the market already pricing in a higher‑for‑longer interest‑rate environment that could postpone a recovery in durable‑goods demand.
Rate Outlook Scenarios
If the Fed maintains a higher‑for‑longer stance, Jefferies recommends buying LyondellBasell (LIN), Corteva (CTVA), International Flavors & Fragrances (IFF) and Kellogg (KWR). Conversely, should the Fed shift its focus to stimulate the home‑equity wealth effect, the firm flags CE, HUN, EMN, MEOH, CBT, DCI and AVNT as buy‑rated names.
Valuation Impact
At current rates, discounted‑cash‑flow (DCF) benchmarks support an approximate 19.0× next‑twelve‑month (NTM) EPS multiple for “ruler” chemical stocks, assuming 5‑6% net‑income growth plus 300‑500 basis points from buybacks and M&A activity. Cyclical specialty chemicals are valued around 16×, falling to about 11× if a recession appears likely within the next two to three years. Commodity chemicals trade at 11‑12×, compressing to 4‑5× under a near‑term recession outlook.
Jefferies’ regression model, calibrated to data from the 1980s‑2000s, suggests a sector‑level warranted NTM P/E of 14‑15×, compared with the current 18.4×. The warranted relative multiple to the S&P 500 would range from 95% to 100% depending on oil‑price movements.
Earnings Sensitivity to Rates
Higher corporate borrowing costs since 2022 continue to affect earnings as companies restructure balance sheets. For roughly half of the chemicals covered, refinancing existing debt at present rates would impose a head‑wind exceeding 1% of EBITDA. The firm estimates that each 100‑basis‑point increase in borrowing costs would reduce EPS for most chemical companies by 1%‑3% and would cut DCF‑based valuation multiples by about 5%, rising to roughly 8% for firms with net‑debt‑to‑EBITDA ratios above 3×.
Methodology Note
The article was generated with AI assistance and subsequently reviewed by an editor, with reference to Jefferies’ internal models and market data.